First Mercantile Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

First Mercantile Trust’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,417	Closed	-$52K	–	1272
2014 Q2	$52K	Sell	5,417 -139	-3%	-$1.24K	﹤0.01%	948
2014 Q1	$46K	Sell	5,556 -16	-0.3%	-$137	﹤0.01%	1071
2013 Q4	$47K	Buy	5,572 +1,066	+24%	+$8.98K	﹤0.01%	983
2013 Q3	$36K	Buy	4,506 +305	+7%	+$2.45K	﹤0.01%	1032
2013 Q2	$32K	Buy	+4,201	New	+$32.8K	﹤0.01%	1044

Other funds holding PDLI

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

First Mercantile Trust's PDLI Position: Q3 2014 in Review

First Mercantile Trust sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 5,417 shares — an estimated $52K sold.

First Mercantile Trust first reported a position in PDLI in Q2 2013 and held it in 5 quarters. The position peaked at $52K in Q2 2014. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

First Mercantile Trust reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
First Mercantile Trust sold 5,417 PDL BioPharma, Inc. shares in Q3 2014, an estimated $52K.
First Mercantile Trust first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 5 quarters.
First Mercantile Trust's PDL BioPharma, Inc. position peaked at $52K in Q2 2014.
231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on First Mercantile Trust's 13F filing for Q3 2014, filed 12 Nov 2014.